Intellectual Property (IP), Artificial Intelligence (AI), Open Movements (OM)

Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD

Showing posts with label Truvada. Show all posts

Thursday, November 7, 2019

Trump administration sues drugmaker Gilead Sciences over patent on Truvada for HIV prevention; The Washington Post, November 7, 2019

Christopher Rowland, The Washington Post; Trump administration sues drugmaker Gilead Sciences over patent on Truvada for HIV prevention

"The Trump administration took the rare step Wednesday of filing a patent infringement lawsuit against pharmaceutical manufacturer Gilead Sciences over sales of Truvada for HIV prevention, a crucial therapy invented and patented by Centers for Disease Control researchers."